trading, page-9

From ABN AMRO Morgan Biotech-Healthcare Snippets and Tips

Idea Of the Week

Avexa(AVX)- AGM next week should provide some good insights.
Buy, Price Target-$1.36, share price 67c, Market Cap: $A272m.
Avexa's AGM is on November 20. We expect that the company will update on the planned start of the Phase 3 trial for it's HIV compound. We believe the Phase 3 trial will commence 1QCY08.
An update on patient recruitment, centres, progress with the FDA on protocols should give the share price another boost.